80 related articles for article (PubMed ID: 21811068)
1. Oxidative and nitrosative stress markers in patients on hemodialysis and peritoneal dialysis.
Köse FA; Seziş M; Akçiçek F; Pabuççuoğlu A
Blood Purif; 2011; 32(3):202-8. PubMed ID: 21811068
[TBL] [Abstract][Full Text] [Related]
2. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
3. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients.
Mitrogianni Z; Barbouti A; Galaris D; Siamopoulos KC
Nephron Clin Pract; 2009; 113(3):c234-40. PubMed ID: 19690441
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of oxidative and nitrosative stress in hemodialysis patients.
Namiduru ES; Tarakcioglu M; Tiryaki O; Usalan C
Minerva Med; 2010 Oct; 101(5):305-10. PubMed ID: 21048552
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
[TBL] [Abstract][Full Text] [Related]
6. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
7. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
Wu CC; Chen JS; Wu WM; Liao TN; Chu P; Lin SH; Chuang CH; Lin YF
Nephrol Dial Transplant; 2005 Jun; 20(6):1134-9. PubMed ID: 15814542
[TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis.
Uzum A; Toprak O; Gumustas MK; Ciftci S; Sen S
J Nephrol; 2006; 19(6):739-45. PubMed ID: 17173246
[TBL] [Abstract][Full Text] [Related]
10. The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis.
Demirci S; Sekeroğlu MR; Noyan T; Köçeroğlu R; Soyoral YU; Dülger H; Erkoç R
Cell Biochem Funct; 2011 Apr; 29(3):249-54. PubMed ID: 21465497
[TBL] [Abstract][Full Text] [Related]
11. Effects of peritoneal-and hemodialysis on levels of plasma protein and lipid oxidation markers in diabetic patients.
Sozer V; Korkmaz Guntas G; Konukoglu D; Dervisoglu E; Gelisgen R; Tabak O; Kalender B; Uzun H
Minerva Med; 2013 Feb; 104(1):75-84. PubMed ID: 23392540
[TBL] [Abstract][Full Text] [Related]
12. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
13. Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure.
Eleuteri E; Di Stefano A; Ricciardolo FL; Magno F; Gnemmi I; Colombo M; Anzalone R; Cappello F; La Rocca G; Tarro Genta F; Zummo G; Giannuzzi P
Int J Cardiol; 2009 Jul; 135(3):386-90. PubMed ID: 19046613
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
15. Protein oxidative stress in dialysis patients.
Doñate T; Herreros A; Martinez E; Martinez J; Andrés E; Cabezas A; Ortiz A; de Prado A; Pou JM; Pamplona R; Portero Otin M; Bellmunt MJ
Adv Perit Dial; 2002; 18():15-7. PubMed ID: 12402579
[TBL] [Abstract][Full Text] [Related]
16. Correlation of oxidative stress biomarkers and peritoneal urea clearance with mitochondrial DNA copy number in continuous ambulatory peritoneal dialysis patients.
Chen JB; Lin TK; Liou CW; Liao SC; Lee LC; Wang PW; Tiao MM
Am J Nephrol; 2008; 28(5):853-9. PubMed ID: 18547945
[TBL] [Abstract][Full Text] [Related]
17. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
18. Protein oxidation status in patients with ankylosing spondylitis.
Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
[TBL] [Abstract][Full Text] [Related]
19. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome.
Baskol G; Korkmaz S; Erdem F; Caniklioglu A; Kocyigit M; Aksu M
Sleep Med; 2012 Apr; 13(4):414-8. PubMed ID: 22469072
[TBL] [Abstract][Full Text] [Related]
20. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
